Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.

Akt1 is frequently up-regulated in human tumors and has been shown to accelerate cell proliferation and to suppress programmed cell death; consequently, inhibition of the activity of Akt1 has been seen as an attractive target for therapeutic intervention. Paradoxically, hyperactivation of the Akt1 oncogene can also prevent the invasive behavior that underlies progression to metastasis. Here we show that overexpression of activated myr-Akt1 in human breast cancer cells phosphorylates and thereby targets the tumor suppressor tuberous sclerosis complex 2 (TSC2) for degradation, leading to reduced Rho-GTPase activity, decreased actin stress fibers and focal adhesions, and reduced motility and invasion. Overexpression of TSC2 rescues the migration phenotype of myr-Akt1-expressing tumor cells, and high levels of TSC2 in breast cancer patients correlate with increased metastasis and reduced survival. These data indicate that the functional properties of genes designated as oncogenes or tumor suppressor genes depend on the context of the cell type and the tissues studied, and suggest the need for caution in designing therapies targeting the function of individual genes in epithelial tissues.

[1]  J. Testa,et al.  Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.

[2]  J. Parsons,et al.  Cell Migration--Movin' On , 1999, Science.

[3]  M J Bissell,et al.  Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression : The Role of Extracellular Matrix and Its Degrading Enzymes , 2022 .

[4]  K. Inoki,et al.  Regulation of TSC2 by 14-3-3 Binding* , 2002, The Journal of Biological Chemistry.

[5]  A. Hall,et al.  Rho GTPases and the actin cytoskeleton. , 1998, Science.

[6]  A. Ridley.  Rho Proteins and Cancer , 2004, Breast Cancer Research and Treatment.

[7]  H. Varmus,et al.  Oncogenes come of age. , 2005, Cold Spring Harbor symposia on quantitative biology.

[8]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[9]  Tian Xu,et al.  Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.

[10]  J. Brugge,et al.  Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition , 2005, The Journal of cell biology.

[11]  V. Krymskaya.  Tumour suppressors hamartin and tuberin: intracellular signalling. , 2003, Cellular signalling.

[12]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[13]  Alan Hall,et al.  Rho GTPases: biochemistry and biology. , 2005, Annual review of cell and developmental biology.

[14]  W. Kaelin,et al.  CANCER-RELEVANT CULLIN-RING UBIQUITIN LIGASES , 2005 .

[15]  B. Kaina,et al.  Rho GTPases are over‐expressed in human tumors , 1999, International journal of cancer.

[16]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[17]  J. Folkman,et al.  Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. , 1977, Microvascular research.

[18]  S. Coons,et al.  Dichotomy of astrocytoma migration and proliferation , 1996, International journal of cancer.

[19]  L. Bourguignon,et al.  Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. , 1999, Cell motility and the cytoskeleton.

[20]  E L Bearer,et al.  Motility‐Related Proteins as Markers for Head and Neck Squamous Cell Cancer , 2001, The Laryngoscope.

[21]  R. Perris.  The extracellular matrix in neural crest-cell migration , 1997, Trends in Neurosciences.

[22]  A. Porter,et al.  Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis , 1998, Oncogene.

[23]  C. Larabell,et al.  Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Jo,et al.  Cooperativity between the Ras-ERK and Rho-Rho Kinase Pathways in Urokinase-type Plasminogen Activator-stimulated Cell Migration* , 2002, The Journal of Biological Chemistry.

[25]  A. Toker,et al.  Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. , 2005, Molecular cell.

[26]  Eric S. Lander,et al.  Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.

[27]  Robert D Cardiff,et al.  Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. , 2004, Cancer research.

[28]  R. Bernards,et al.  The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene , 2005, Nature Cell Biology.

[29]  H. Koh,et al.  Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  J. Woodgett,et al.  PKB/AKT: functional insights from genetic models , 2001, Nature Reviews Molecular Cell Biology.

[31]  J. Thiery,et al.  Involvement of cell motility in tumor progression. , 1993, Symposia of the Society for Experimental Biology.

[32]  D. Yamazaki,et al.  Regulation of cancer cell motility through actin reorganization , 2005, Cancer science.

[33]  M. Bissell,et al.  Inability of Rous sarcoma virus to cause sarcomas in the avian embryo , 1984, Nature.

[34]  M. Sporn,et al.  Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta. , 1990, Science.

[35]  D. Theodorescu,et al.  The role of Ral A in epidermal growth factor receptor-regulated cell motility. , 2002, Cancer research.

[36]  W. Cardoso,et al.  Bud formation precedes the appearance of differential cell proliferation during branching morphogenesis of mouse lung epithelium in vitro , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[37]  B. Karlan,et al.  Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. , 2003, Cancer research.

[38]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[39]  J. Cheng,et al.  Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas , 1998, Molecular carcinogenesis.

[40]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[41]  I. Pass,et al.  The SRC substrate Tks5, podosomes (invadopodia), and cancer cell invasion. , 2005, Cold Spring Harbor symposia on quantitative biology.

[42]  Huan Yang,et al.  The Akt/PKB pathway: molecular target for cancer drug discovery , 2005, Oncogene.

[43]  Kennichi Satoh,et al.  Myosin Light Chain Kinase Inhibitors Can Block Invasion and Adhesion of Human Pancreatic Cancer Cell Lines , 2002, Pancreas.

[44]  K. Inoki,et al.  The p38 and MK2 Kinase Cascade Phosphorylates Tuberin, the Tuberous Sclerosis 2 Gene Product, and Enhances Its Interaction with 14-3-3* , 2003, The Journal of Biological Chemistry.

[45]  J. Testa,et al.  AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. , 2001, Cancer research.

[46]  J. Testa,et al.  Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions. , 2004, Carcinogenesis.

[47]  H. Vinters,et al.  The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho , 2000, Nature Cell Biology.

[48]  D. Cheresh,et al.  Bifurcation of Cell Migratory and Proliferative Signaling by the Adaptor Protein Shc , 1999, The Journal of cell biology.

[49]  M. Waterfield,et al.  Synthesis and function of 3-phosphorylated inositol lipids. , 2001, Annual review of biochemistry.

[50]  G. von Dassow,et al.  A microtubule-dependent zone of active RhoA during cleavage plane specification , 2005, The Journal of cell biology.

[51]  M. Tatsuta,et al.  Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. , 2001, Cancer research.

[52]  C. Walker,et al.  14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). , 2002, Cancer research.

[53]  O. Petersen,et al.  Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. , 1996, Cancer research.

[54]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[55]  S. Nicosia,et al.  Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin* , 2002, The Journal of Biological Chemistry.

[56]  R. Yeung,et al.  The Tuberous Sclerosis Complex Genes in Tumor Development , 2004, Cancer investigation.

[57]  P. Friedl,et al.  Tumour-cell invasion and migration: diversity and escape mechanisms , 2003, Nature Reviews Cancer.

[58]  Thomas D Pollard,et al.  Cellular Motility Driven by Assembly and Disassembly of Actin Filaments , 2003, Cell.

[59]  E. Henske,et al.  Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration , 2002, Oncogene.

[60]  H. Barth,et al.  The golgi-associated COPI-coated buds and vesicles contain beta/gamma -actin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Y. Murakumo,et al.  Akt/PKB regulates actin organization and cell motility via Girdin/APE. , 2005, Developmental cell.

[62]  D. Radisky,et al.  Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells , 2004, The Journal of cell biology.

[63]  K. Inoki,et al.  TSC2: filling the GAP in the mTOR signaling pathway. , 2004, Trends in biochemical sciences.

[64]  A. V. D. van den Ouweland,et al.  Identification and Characterization of the Interaction between Tuberin and 14-3-3ζ* , 2002, The Journal of Biological Chemistry.

[65]  P. Penar,et al.  Brain Tumor Invasion Rate Measured In Vitro Does Not Correlate with Ki-67 Expression , 2004, Journal of Neuro-Oncology.

[66]  A. Barthel,et al.  A Constitutively Active Version of the Ser/Thr Kinase Akt Induces Production of the obGene Product, Leptin, in 3T3-L1 Adipocytes. , 1997, Endocrinology.

[67]  Kun-Liang Guan,et al.  Dysregulation of the TSC-mTOR pathway in human disease , 2004, Nature Genetics.

[68]  D. Noonan,et al.  TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase , 2004, The Journal of cell biology.

[69]  T. Hunter,et al.  Oncogenic kinase signalling , 2001, Nature.

[70]  C. Myers,et al.  Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. , 2000, Biochemical and biophysical research communications.

[71]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[72]  D. Alessi,et al.  TSC1–TSC2: a complex tale of PKB-mediated S6K regulation , 2002, Nature Cell Biology.

[73]  P. Keely,et al.  R-Ras controls membrane protrusion and cell migration through the spatial regulation of Rac and Rho. , 2004, Molecular biology of the cell.

[74]  J. Testa,et al.  Activation of AKT kinases in cancer: implications for therapeutic targeting. , 2005, Advances in cancer research.

[75]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.